155 related articles for article (PubMed ID: 12163498)
21. Cloning and characterization of the promoter region of the rat taurine transporter (TauT) gene.
Han X; Budreau AM; Chesney RW
Adv Exp Med Biol; 2000; 483():97-108. PubMed ID: 11787653
[No Abstract] [Full Text] [Related]
22. Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity.
Liu X; Yue P; Khuri FR; Sun SY
Cancer Res; 2005 Oct; 65(20):9169-75. PubMed ID: 16230375
[TBL] [Abstract][Full Text] [Related]
23. Osmoregulation of taurine transporter function and expression in retinal pigment epithelial, ganglion, and müller cells.
El-Sherbeny A; Naggar H; Miyauchi S; Ola MS; Maddox DM; Martin PM; Ganapathy V; Smith SB
Invest Ophthalmol Vis Sci; 2004 Feb; 45(2):694-701. PubMed ID: 14744916
[TBL] [Abstract][Full Text] [Related]
24. p53 stimulates transcription from the human transforming growth factor alpha promoter: a potential growth-stimulatory role for p53.
Shin TH; Paterson AJ; Kudlow JE
Mol Cell Biol; 1995 Sep; 15(9):4694-701. PubMed ID: 7651386
[TBL] [Abstract][Full Text] [Related]
25. Regulation of expression of taurine transport in two continuous renal epithelial cell lines and inhibition of taurine transporter by a site-directed antibody.
Han X; Chesney RW; Budreau AM; Jones DP
Adv Exp Med Biol; 1996; 403():173-91. PubMed ID: 8915355
[TBL] [Abstract][Full Text] [Related]
26. Identification of competitive inhibitors of the human taurine transporter TauT in a human kidney cell line.
Richter M; Moroniak SJ; Michel H
Pharmacol Rep; 2019 Feb; 71(1):121-129. PubMed ID: 30612046
[TBL] [Abstract][Full Text] [Related]
27. Functional characterization and regulation of the taurine transporter and cysteine dioxygenase in human hepatoblastoma HepG2 cells.
Satsu H; Terasawa E; Hosokawa Y; Shimizu M
Biochem J; 2003 Oct; 375(Pt 2):441-7. PubMed ID: 12871209
[TBL] [Abstract][Full Text] [Related]
28. Identification of regulatory regions within the KAI1 promoter: a role for binding of AP1, AP2 and p53.
Marreiros A; Czolij R; Yardley G; Crossley M; Jackson P
Gene; 2003 Jan; 302(1-2):155-64. PubMed ID: 12527206
[TBL] [Abstract][Full Text] [Related]
29. Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma.
Qiu W; Zhou B; Zou H; Liu X; Chu PG; Lopez R; Shih J; Chung C; Yen Y
Am J Pathol; 2004 Nov; 165(5):1689-99. PubMed ID: 15509538
[TBL] [Abstract][Full Text] [Related]
30. The taurine transporter gene and its role in renal development.
Han X; Budreau AM; Chesney RW
Amino Acids; 2000; 19(3-4):499-507. PubMed ID: 11140355
[TBL] [Abstract][Full Text] [Related]
31. p21/CDKN1A mediates negative regulation of transcription by p53.
Löhr K; Möritz C; Contente A; Dobbelstein M
J Biol Chem; 2003 Aug; 278(35):32507-16. PubMed ID: 12748190
[TBL] [Abstract][Full Text] [Related]
32. A promoter function of the CCCGGG Sma I recognition sequence and its specific role in determining p53 status and identifying DNA damaging agents.
Yang AL; Festing MF
Biochem Biophys Res Commun; 2001 Feb; 281(2):506-10. PubMed ID: 11181076
[TBL] [Abstract][Full Text] [Related]
33. Osmoregulated taurine transport in H4IIE hepatoma cells and perfused rat liver.
Warskulat U; Wettstein M; Häussinger D
Biochem J; 1997 Feb; 321 ( Pt 3)(Pt 3):683-90. PubMed ID: 9032454
[TBL] [Abstract][Full Text] [Related]
34. Cloning of the mouse insulin receptor substrate-3 (mIRS-3) promoter, and its regulation by p53.
Sciacchitano S; Orecchio A; Lavra L; Misiti S; Giacchini A; Zani M; Danese D; Gurtner A; Soddu S; Di Mario U; Andreoli M
Mol Endocrinol; 2002 Jul; 16(7):1577-89. PubMed ID: 12089352
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of TauT in protecting against cisplatin-induced kidney injury (AKI).
Han X; Chesney RW
Adv Exp Med Biol; 2009; 643():105-12. PubMed ID: 19239141
[TBL] [Abstract][Full Text] [Related]
36. NDRG1 is necessary for p53-dependent apoptosis.
Stein S; Thomas EK; Herzog B; Westfall MD; Rocheleau JV; Jackson RS; Wang M; Liang P
J Biol Chem; 2004 Nov; 279(47):48930-40. PubMed ID: 15377670
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of regulation of taurine transporter activity: a complex interplay of regulatory systems.
Han X; Chesney RW
Adv Exp Med Biol; 2006; 583():79-90. PubMed ID: 17153591
[No Abstract] [Full Text] [Related]
38. Transcriptional activation of the human stress-inducible transcriptional repressor ATF3 gene promoter by p53.
Zhang C; Gao C; Kawauchi J; Hashimoto Y; Tsuchida N; Kitajima S
Biochem Biophys Res Commun; 2002 Oct; 297(5):1302-10. PubMed ID: 12372430
[TBL] [Abstract][Full Text] [Related]
39. Human placental taurine transporter in uncomplicated and IUGR pregnancies: cellular localization, protein expression, and regulation.
Roos S; Powell TL; Jansson T
Am J Physiol Regul Integr Comp Physiol; 2004 Oct; 287(4):R886-93. PubMed ID: 15166008
[TBL] [Abstract][Full Text] [Related]
40. Blunted apoptosis of erythrocytes from taurine transporter deficient mice.
Lang PA; Warskulat U; Heller-Stilb B; Huang DY; Grenz A; Myssina S; Duszenko M; Lang F; Häussinger D; Vallon V; Wieder T
Cell Physiol Biochem; 2003; 13(6):337-46. PubMed ID: 14631140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
